Legend Biotech US
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.
Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.
Is Legend Biotech US hiring?
Yes — Legend Biotech US has 69 open jobs on JobsRadar right now, across 84 departments and 7 locations. 29 of them were opened in the last 30 days. 66 of them disclose pay, with a median of $147,206 a year and most offers between $111,309 and $194,680. The board was last refreshed on August 15, 2026 at 05:00 UTC.
Frequently asked questions
- Is Legend Biotech US hiring?
- Yes. Legend Biotech US has 69 open jobs on JobsRadar as of August 15, 2026. 29 of them were opened in the last 30 days.
- What roles is Legend Biotech US hiring for?
- Legend Biotech US is hiring for roles in Operations - Raritan, Facilities & Engineering, Global Translational Research and Process Analytical Development.
- What does Legend Biotech US pay?
- Across the 66 Legend Biotech US jobs that disclose pay, the median is $147,206 a year, and most offers fall between $111,309 and $194,680.
- How current are these listings?
- Every listing comes straight from the employer’s own careers system and is re-checked three times a day. This page was last updated on August 15, 2026 at 05:00 UTC.